Cargando…

Statins and the Brain: More than Lipid Lowering Agents?

BACKGROUND: Statins represent a class of medications widely prescribed to efficiently treat dyslipidemia. These drugs inhibit 3-βhydroxy 3β-methylglutaryl Coenzyme A reductase (HMGR), the rate-limiting enzyme of mevalonate (MVA) pathway. Besides cholesterol, MVA pathway leads to the production of se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fracassi, Anna, Marangoni, Martina, Rosso, Pamela, Pallottini, Valentina, Fioramonti, Marco, Siteni, Silvia, Segatto, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341496/ https://www.ncbi.nlm.nih.gov/pubmed/28676012 http://dx.doi.org/10.2174/1570159X15666170703101816

Ejemplares similares

Neurotrophins as Key Regulators of Cell Metabolism: Implications for Cholesterol Homeostasis
por: Colardo, Mayra, et al.
Publicado: (2021)

Facts about Fats: New Insights into the Role of Lipids in Metabolism, Disease and Therapy
por: Segatto, Marco, et al.
Publicado: (2020)

Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease
por: Segatto, Marco, et al.
Publicado: (2013)

Fat Checking: Emerging Role of Lipids in Metabolism and Disease
por: Segatto, Marco, et al.
Publicado: (2022)

Impact of Sex and Age on the Mevalonate Pathway in the Brain: A Focus on Effects Induced by Maternal Exposure to Exogenous Compounds
por: Tonini, Claudia, et al.
Publicado: (2020)

Loss of Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and Rett Syndrome
por: Segatto, Marco, et al.
Publicado: (2019)

Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype
por: Pallottini, Valentina, et al.
Publicado: (2022)

Prenatal Exposure to BPA: The Effects on Hepatic Lipid Metabolism in Male and Female Rat Fetuses
por: Tonini, Claudia, et al.
Publicado: (2021)

Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis
por: Tonini, Claudia, et al.
Publicado: (2020)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

Effects of Late-Life Caloric Restriction on Age-Related Alterations in the Rat Cortex and Hippocampus
por: Tonini, Claudia, et al.
Publicado: (2021)

Maternal Dietary Exposure to Low-Dose Bisphenol A Affects Metabolic and Signaling Pathways in the Brain of Rat Fetuses
por: Tonini, Claudia, et al.
Publicado: (2020)

NGF Modulates Cholesterol Metabolism and Stimulates ApoE Secretion in Glial Cells Conferring Neuroprotection against Oxidative Stress
por: Colardo, Mayra, et al.
Publicado: (2022)

Pleiotropic and Lipid–lowering Effects of Statins in Hypertension
por: Kamberi, Lulzim Selim, et al.
Publicado: (2012)

Lipid-lowering drugs (statins) and peripheral neuropathy
por: Emad, Mohammadreza, et al.
Publicado: (2018)

Cholesterol Metabolism Is Altered in Rett Syndrome: A Study on Plasma and Primary Cultured Fibroblasts Derived from Patients
por: Segatto, Marco, et al.
Publicado: (2014)

Statin-Related Necrotizing Autoimmune Myositis: More Than Myalgia
por: Scheuing, William J, et al.
Publicado: (2022)

Glycaemic Effects of Non-statin Lipid-Lowering Therapies
por: Collins, Patrick D., et al.
Publicado: (2016)

Pleiotropic use of Statins as non-lipid-lowering drugs
por: Zhang, Qijia, et al.
Publicado: (2020)

Management of Statin Intolerance in 2018: Still More Questions Than Answers
por: Toth, Peter P., et al.
Publicado: (2018)

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

ProNGF/p75NTR Axis Drives Fiber Type Specification by Inducing the Fast-Glycolytic Phenotype in Mouse Skeletal Muscle Cells
por: Pallottini, Valentina, et al.
Publicado: (2020)

Use of Statins as Lipid Lowering Agent in Hypercholesterolemia in a Tertiary Care Hospital: A Descriptive Cross-sectional Study
por: Bhattarai, Ashish Kumar, et al.
Publicado: (2020)

Statin therapy and lipids-lowering supplements – safe and effective treatment of lipids disturbances in children
por: Grabarczyk, Małgorzata, et al.
Publicado: (2022)

There is more to NPH than lower body Parkinsonism
por: Oertel, Joachim M. K., et al.
Publicado: (2021)

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2019)

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
por: Rea, Federico, et al.
Publicado: (2021)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
por: Morofuji, Yoichi, et al.
Publicado: (2022)

Is There More to Olive Oil than Healthy Lipids?
por: Isaakidis, Akritas, et al.
Publicado: (2023)

Long-Lasting Impact of Sugar Intake on Neurotrophins and Neurotransmitters from Adolescence to Young Adulthood in Rat Frontal Cortex
por: Spagnuolo, Maria Stefania, et al.
Publicado: (2022)

NGF Prevents Loss of TrkA/VEGFR2 Cells, and VEGF Isoform Dysregulation in the Retina of Adult Diabetic Rats
por: Fico, Elena, et al.
Publicado: (2022)

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
por: Barber, Mathew J., et al.
Publicado: (2010)

More than just internists()
por: Zapatero Gaviria, A., et al.
Publicado: (2020)

Novel Uses for Lipid-Lowering Agents
por: May, Megan Brafford, et al.
Publicado: (2016)

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy
por: Ikegami, Yuichi, et al.
Publicado: (2018)

Advances in HDL: Much More than Lipid Transporters
por: Ben-Aicha, Soumaya, et al.
Publicado: (2020)

Lipid-lowering therapy using statins in patients with cardiovascular risk in clinical practice in Thailand
por: Silaruks, Songkwan, et al.
Publicado: (2011)

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment
por: Ruiz-Iruela, Cristina, et al.
Publicado: (2018)

Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
por: Parhofer, Klaus G.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3a4bm4r9n5h5agvf3v7l6rdq2